Tanya Lewis Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Tanya Lewis.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Tanya Lewis. Tanya Lewis is VP Regulatory and Quality in VION PHARMACEUTICALS INC ($VION) and EVP, Chief Reg. Affairs in Karyopharm Therapeutics Inc. ($KPTI) and EVP,Chief Reg.&Quality Officer in Karyopharm Therapeutics Inc. ($KPTI) and Chief Dev. Oper. Off. in Replimune Group, Inc. ($REPL) and Director in Replimune Group, Inc. ($REPL).
Latest Insider Trading Transactions of Tanya Lewis
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, KPTI, REPL, VION
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11 2021 | REPL | Replimune Group, I ... | Lewis Tanya | Chief Dev. Oper. Of ... | Option Exercise | A | 33.99 | 110,000 | 3,738,900 | 110,000 | |
| May 11 2021 | REPL | Replimune Group, I ... | Lewis Tanya | Chief Dev. Oper. Of ... | Grant | A | 0.00 | 73,333 | 0 | 73,333 | 0 to 73.3 K |
| Apr 05 2021 | REPL | Replimune Group, I ... | Lewis Tanya | Director | Option Exercise | A | 31.58 | 16,500 | 521,070 | 16,500 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP, Chief Reg. Aff ... | Option Exercise | A | 14.56 | 59,968 | 873,134 | 59,968 | |
| Mar 01 2021 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP, Chief Reg. Aff ... | Grant | A | 0.00 | 22,013 | 0 | 45,401 | 23.4 K to 45.4 K (+94.12 %) |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP, Chief Reg. Aff ... | Option Exercise | M | 0.00 | 5,650 | 0 | 16,950 | |
| Feb 09 2021 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP, Chief Reg. Aff ... | Buy | M | 0.00 | 5,650 | 0 | 6,189 | 539 to 6.2 K (+1,048.24 %) |
| Nov 04 2020 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP,Chief Reg.&Qual ... | Option Exercise | M | 0.00 | 765 | 0 | 2,295 | |
| Nov 04 2020 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP,Chief Reg.&Qual ... | Sell | S | 15.58 | 226 | 3,521 | 539 | 765 to 539 (-29.54 %) |
| Nov 04 2020 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP,Chief Reg.&Qual ... | Buy | M | 0.00 | 765 | 0 | 765 | 0 to 765 |
| Nov 03 2020 | REPL | Replimune Group, I ... | Lewis Tanya | Director | Option Exercise | A | 42.00 | 33,000 | 1,386,000 | 33,000 | |
| Feb 07 2020 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP,Chief Reg.&Qual ... | Option Exercise | A | 0.00 | 22,600 | 0 | 22,600 | |
| Feb 07 2020 | KPTI | Karyopharm Therape ... | Lewis Tanya | EVP,Chief Reg.&Qual ... | Option Exercise | A | 18.00 | 60,600 | 1,090,800 | 60,600 | |
| Dec 12 2008 | VION | VION PHARMACEUTICA ... | Lewis Tanya | VP Regulatory and Q ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Page: 1